X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (19765) 19765
Newsletter (132) 132
Book Chapter (25) 25
Dissertation (14) 14
Publication (12) 12
Book / eBook (7) 7
Web Resource (5) 5
Conference Proceeding (4) 4
Magazine Article (3) 3
Transcript (2) 2
Government Document (1) 1
Newspaper Article (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (13527) 13527
paclitaxel (11448) 11448
paclitaxel - pharmacology (7207) 7207
female (7192) 7192
animals (6910) 6910
pharmacology & pharmacy (6560) 6560
oncology (6496) 6496
cancer (4906) 4906
chemotherapy (4634) 4634
cell line, tumor (4535) 4535
mice (3721) 3721
male (3612) 3612
paclitaxel - administration & dosage (3558) 3558
antineoplastic agents, phytogenic - pharmacology (2946) 2946
antineoplastic agents - pharmacology (2928) 2928
middle aged (2794) 2794
apoptosis (2736) 2736
taxol (2619) 2619
aged (2436) 2436
apoptosis - drug effects (2265) 2265
adult (2171) 2171
nanoparticles (2077) 2077
antineoplastic combined chemotherapy protocols - therapeutic use (2003) 2003
breast neoplasms - drug therapy (1897) 1897
drug delivery systems (1820) 1820
in-vitro (1776) 1776
paclitaxel - therapeutic use (1754) 1754
breast cancer (1747) 1747
cell survival - drug effects (1722) 1722
expression (1722) 1722
dose-response relationship, drug (1678) 1678
cisplatin (1607) 1607
drugs (1578) 1578
biochemistry & molecular biology (1538) 1538
treatment outcome (1529) 1529
tumors (1526) 1526
analysis (1525) 1525
docetaxel (1524) 1524
research (1488) 1488
therapy (1474) 1474
paclitaxel - chemistry (1448) 1448
cell proliferation - drug effects (1446) 1446
tumor cells, cultured (1437) 1437
doxorubicin (1415) 1415
antineoplastic agents (1401) 1401
drug resistance, neoplasm (1390) 1390
microtubules - drug effects (1374) 1374
ovarian neoplasms - drug therapy (1370) 1370
cell biology (1359) 1359
mice, nude (1345) 1345
antineoplastic agents, phytogenic - administration & dosage (1326) 1326
antimitotic agents (1292) 1292
care and treatment (1280) 1280
rats (1256) 1256
breast neoplasms - pathology (1252) 1252
cells (1251) 1251
pharmacokinetics (1233) 1233
lung neoplasms - drug therapy (1221) 1221
antineoplastic agents - therapeutic use (1211) 1211
paclitaxel - pharmacokinetics (1184) 1184
breast-cancer (1181) 1181
neoplasms - drug therapy (1177) 1177
chemistry, multidisciplinary (1158) 1158
ovarian cancer (1154) 1154
xenograft model antitumor assays (1122) 1122
chemistry, medicinal (1070) 1070
pharmacology/toxicology (1061) 1061
paclitaxel - adverse effects (1057) 1057
carcinoma (1054) 1054
antineoplastic agents - administration & dosage (1049) 1049
carboplatin (1037) 1037
cytotoxicity (1034) 1034
cancer therapies (1026) 1026
drug-delivery (1015) 1015
micelles (1008) 1008
medicine & public health (994) 994
proteins (991) 991
drug synergism (981) 981
time factors (977) 977
mice, inbred balb c (969) 969
drug therapy (967) 967
nanoparticles - chemistry (961) 961
paclitaxel - analogs & derivatives (960) 960
antineoplastic agents, phytogenic - therapeutic use (956) 956
antineoplastic combined chemotherapy protocols - adverse effects (952) 952
drug resistance (951) 951
metastasis (943) 943
combination (910) 910
drug carriers - chemistry (909) 909
trial (879) 879
health aspects (871) 871
particle size (871) 871
microtubules (864) 864
vehicles (864) 864
microtubules - metabolism (857) 857
resistance (854) 854
ovarian neoplasms - pathology (846) 846
pharmacology (845) 845
toxicity (839) 839
delivery (837) 837
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (19705) 19705
Chinese (224) 224
Japanese (209) 209
French (42) 42
Russian (24) 24
German (16) 16
Italian (10) 10
Spanish (10) 10
Polish (6) 6
Dutch (5) 5
Korean (4) 4
Portuguese (3) 3
Czech (2) 2
Hungarian (2) 2
Croatian (1) 1
Finnish (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Biological Chemistry, ISSN 0021-9258, 07/2014, Volume 289, Issue 30, pp. 21082 - 21097
Journal Article
Neuroscience, ISSN 0306-4522, 2011, Volume 193, pp. 440 - 451
Abstract Paclitaxel chemotherapy is limited by a long-lasting painful neuropathy that lacks an effective therapy. In this study, we tested the hypothesis that... 
Neurology | mast cell tryptase | paclitaxel-induced pain | TRPV1 | TRPA1 | proteinase-activated receptor 2 | TRPV4 | Proteinase-activated receptor 2 | Mast cell tryptase | Paclitaxel-induced pain | NEUROSCIENCES | SENSORY NEURONS | CAPSAICIN RECEPTOR | MECHANICAL HYPERALGESIA | IN-VIVO | KINASE-C-EPSILON | ION-CHANNEL | PERIPHERAL NEUROPATHY | INFLAMMATORY PAIN | PROTEASE-ACTIVATED-RECEPTOR-2 SENSITIZES | IRRITABLE-BOWEL-SYNDROME | Tryptases - metabolism | Central Nervous System - metabolism | Capsaicin - pharmacology | Receptor, PAR-2 - metabolism | Type C Phospholipases - metabolism | Male | Neuralgia - pathology | Dose-Response Relationship, Drug | TRPV Cation Channels - metabolism | Receptor, PAR-2 - antagonists & inhibitors | Drug Interactions | Paclitaxel - toxicity | Time Factors | Protein Kinase C - metabolism | TRPV Cation Channels - antagonists & inhibitors | Estrenes - pharmacology | Pyrrolidinones - pharmacology | Neuralgia - chemically induced | Neuralgia - physiopathology | Disease Models, Animal | Cyclic AMP-Dependent Protein Kinases - metabolism | Enzyme Inhibitors - pharmacology | Capsaicin - analogs & derivatives | Sulfonamides - pharmacology | Cinnamates - pharmacology | Mice, Inbred ICR | Hyperalgesia - physiopathology | Antineoplastic Agents, Phytogenic - toxicity | Gene Expression Regulation - drug effects | Pain Measurement - methods | Pyrroles - pharmacology | Animals | Analysis of Variance | Ankyrins - antagonists & inhibitors | Anilides - pharmacology | Ankyrins - metabolism | Central Nervous System - drug effects | Mice | Physical Stimulation - adverse effects | Carbazoles - pharmacology | Oligopeptides - pharmacology | Protein Kinase C - pharmacology | Enzymes | Care and treatment | Neurosciences | Paclitaxel | Phospholipases | Protein kinases | Cancer
Journal Article
JNCI : Journal of the National Cancer Institute, ISSN 1460-2105, 2004, Volume 96, Issue 10, pp. 739 - 749
Background. Trastuzumab, a humanized anti-HER2 antibody, increases the clinical benefit of first-line chemotherapy in patients with metastatic breast cancers... 
TUMOR-CELL LINES | GROWTH-FACTOR RECEPTOR | PHASE-II TRIAL | IN-VITRO | PACLITAXEL TAXOL(R) | ONCOLOGY | 1ST-LINE CHEMOTHERAPY | RANDOMIZED-TRIAL | MONOCLONAL-ANTIBODY | CLINICAL PHARMACOKINETICS | DOCETAXEL TAXOTERE(R) | Up-Regulation | Cyclophosphamide - analogs & derivatives | Paclitaxel - pharmacology | Taxoids - pharmacology | Neoplastic Stem Cells - drug effects | Humans | Receptor, ErbB-2 - metabolism | Deoxycytidine - pharmacology | Transplantation, Heterologous | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Breast Neoplasms - metabolism | Antibodies, Monoclonal, Humanized | Vinblastine - analogs & derivatives | Female | Gene Expression Regulation, Neoplastic - drug effects | Receptor, ErbB-2 - drug effects | Disease Models, Animal | Floxuridine - pharmacology | Cell Survival - drug effects | Tumor Stem Cell Assay | Proto-Oncogene Proteins - drug effects | Enzyme-Linked Immunosorbent Assay | Antibodies, Monoclonal - pharmacology | Docetaxel | Breast Neoplasms - drug therapy | DNA, Neoplasm - drug effects | Guanine Nucleotide Exchange Factors | Drug Synergism | Animals | Mice, Nude | Cyclophosphamide - pharmacology | Cell Line, Tumor | Mice | Vinblastine - pharmacology | Carboplatin - pharmacology | Deoxycytidine - analogs & derivatives | Doxorubicin - pharmacology | Trastuzumab | Vinorelbine | Epirubicin - pharmacology | Chemotherapy | Care and treatment | Breast cancer | Research | Health aspects
Journal Article
Clinical cancer research, ISSN 1557-3265, 2008, Volume 14, Issue 20, pp. 6456 - 6468
Purpose: It was the aim of our study to establish an extensive panel of non-small cell lung cancer (NSCLC) xenograft models useful for the testing of novel... 
xenograft | NSCLC | erlotinib | mutational analysis | anti-EGFR therapy | cetuximab | biomarker | KRAS MUTATIONS | GROWTH-FACTOR RECEPTOR | GEFITINIB | ONCOLOGY | GENE-EXPRESSION | RESISTANCE | EGFR MUTATIONS | KINASE INHIBITORS | ANTITUMOR-ACTIVITY | CHEMOTHERAPY | ZD1839 | Carcinoma, Large Cell - drug therapy | Lung Neoplasms - drug therapy | Receptor, Epidermal Growth Factor - genetics | Adenocarcinoma - pathology | Oligonucleotide Array Sequence Analysis | Carcinoma, Large Cell - pathology | Carcinoma, Squamous Cell - pathology | Humans | Lung Neoplasms - metabolism | Middle Aged | Drug Resistance, Neoplasm | Immunoblotting | Male | Gene Expression Profiling | Adenocarcinoma - metabolism | Biomarkers, Tumor - metabolism | Cetuximab | Disease Models, Animal | Genes, ras - genetics | Antibodies, Monoclonal - pharmacology | Carcinoma, Non-Small-Cell Lung - metabolism | Etoposide - pharmacology | Mutation - genetics | Adenocarcinoma - drug therapy | Small Cell Lung Carcinoma - pathology | Carcinoma, Squamous Cell - drug therapy | Mice, Nude | Mice, Inbred NOD | Biomarkers, Tumor - genetics | Mice | Carboplatin - pharmacology | Quinazolines - pharmacology | Deoxycytidine - analogs & derivatives | Erlotinib Hydrochloride | Paclitaxel - pharmacology | Prognosis | Carcinoma, Squamous Cell - metabolism | Deoxycytidine - pharmacology | Lung Neoplasms - pathology | Small Cell Lung Carcinoma - drug therapy | Tumor Suppressor Protein p53 - genetics | Small Cell Lung Carcinoma - metabolism | Antibodies, Monoclonal, Humanized | Receptor, Epidermal Growth Factor - metabolism | Vinblastine - analogs & derivatives | Polymerase Chain Reaction | Adult | Female | Antineoplastic Agents - pharmacology | Carcinoma, Non-Small-Cell Lung - pathology | Carcinoma, Large Cell - metabolism | Radiation-Sensitizing Agents - pharmacology | Tumor Suppressor Protein p53 - metabolism | Mice, SCID | Xenograft Model Antitumor Assays | Animals | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Aged | Protein Kinase Inhibitors - pharmacology | Vinblastine - pharmacology | Carcinoma, Non-Small-Cell Lung - drug therapy | Antineoplastic Agents, Phytogenic - pharmacology
Journal Article
Cancer Letters, ISSN 0304-3835, 2012, Volume 320, Issue 1, pp. 104 - 110
Abstract Molecularly targeted therapies have emerged as the leading theme in cancer therapeutics. Multi-cytotoxic drug regimens have been highly successful,... 
Hematology, Oncology and Palliative Medicine | Combination index | Dasatinib | Molecular targeted therapy | Rapamycin | ACTIVATION | SRC | BCR-ABL | TUMOR | MECHANISMS | SIMULATION | CHEMOTHERAPY | ONCOLOGY | RESISTANCE | SYSTEMS | KINASES | Niacinamide - analogs & derivatives | Paclitaxel - pharmacology | Nitriles - pharmacology | Humans | Epothilones - pharmacology | Thiazoles - administration & dosage | Chromones - administration & dosage | Phenylurea Compounds | Benzenesulfonates - administration & dosage | Tamoxifen - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Dose-Response Relationship, Drug | Nitriles - administration & dosage | Benzenesulfonates - pharmacology | Female | Chromones - pharmacology | Paclitaxel - administration & dosage | Butadienes - pharmacology | Pyridines - administration & dosage | Pyrimidines - administration & dosage | Morpholines - administration & dosage | Enzyme Inhibitors - pharmacology | Morpholines - pharmacology | Pyrimidines - pharmacology | Breast Neoplasms - drug therapy | Sirolimus - pharmacology | Drug Synergism | Sirolimus - administration & dosage | Signal Transduction - drug effects | Butadienes - administration & dosage | Epothilones - administration & dosage | Tamoxifen - pharmacology | Cell Line, Tumor | Pyridines - pharmacology | Thiazoles - pharmacology | Care and treatment | Oncology, Experimental | Genes | Breast cancer | Research | Tamoxifen | Cancer | Index Medicus
Journal Article
Journal of clinical pharmacology, ISSN 0091-2700, 2014, Volume 54, Issue 10, pp. 1097 - 1107
Journal Article
Biomaterials, ISSN 0142-9612, 2014, Volume 35, Issue 21, pp. 5591 - 5604
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 5/2011, Volume 67, Issue 5, pp. 1157 - 1166
Journal Article
Proceedings of the National Academy of Sciences - PNAS, ISSN 0027-8424, 12/2008, Volume 105, Issue 49, pp. 19306 - 19311
Journal Article
Clinical cancer research, ISSN 1557-3265, 2005, Volume 11, Issue 20, pp. 7508 - 7515
Purpose: BRCA2, FANCC , and FANCG gene mutations are present in a subset of pancreatic cancer. Defects in these genes could lead to hypersensitivity to... 
BRCA1, BRCA2 | Xenograft models | DNA damage and repair mechanisms | Pharmacogenetics/pharmacogenomics | Gastrointestinal cancers: other | GENE-MUTATIONS | LUNG-CANCER | FUNCTIONAL-ACTIVITY | ONCOLOGY | ABL TYROSINE KINASE | MITOMYCIN-C | PANCREATIC-CANCER | RANDOMIZED-TRIAL | PHASE-II | COMPLEMENTATION GROUP | CARCINOMA | Paclitaxel - pharmacology | Apoptosis - drug effects | Cross-Linking Reagents - pharmacology | Humans | Deoxycytidine - pharmacology | Chlorambucil - pharmacology | Fanconi Anemia Complementation Group C Protein - genetics | Dose-Response Relationship, Drug | Pancreatic Neoplasms - drug therapy | Caspases - metabolism | Fanconi Anemia Complementation Group G Protein - genetics | Time Factors | Cross-Linking Reagents - therapeutic use | Fanconi Anemia Complementation Group G Protein - deficiency | Inhibitory Concentration 50 | Female | Antineoplastic Agents - pharmacology | Melphalan - pharmacology | Cell Survival - drug effects | Fanconi Anemia Complementation Group Proteins - deficiency | Mitomycin - therapeutic use | Pancreatic Neoplasms - pathology | Fanconi Anemia Complementation Group Proteins - genetics | Etoposide - pharmacology | Pancreatic Neoplasms - genetics | Cisplatin - pharmacology | Xenograft Model Antitumor Assays - methods | Mitomycin - pharmacology | Animals | Mice, Nude | Cell Line, Tumor | Fanconi Anemia Complementation Group C Protein - deficiency | BRCA2 Protein - deficiency | Fluorouracil - pharmacology | Mice | Vinblastine - pharmacology | Mutation | Cell Cycle - drug effects | BRCA2 Protein - genetics | Deoxycytidine - analogs & derivatives | Doxorubicin - pharmacology
Journal Article
Pharmaceutical research, ISSN 1573-904X, 2015, Volume 32, Issue 6, pp. 2003 - 2014
The blood–brain barrier (BBB) essentially restricts therapeutic drugs from entering into the brain. This study tests the hypothesis that brain endothelial cell... 
Biochemistry, general | Biomedical Engineering | Biomedicine | blood–brain barrier | Pharmacy | Medical Law | brain cancer | drug delivery | zebrafish | Pharmacology/Toxicology | exosome | blood-brain barrier | SYSTEM | CELLS | HPLC METHOD | MODEL | CHEMISTRY, MULTIDISCIPLINARY | TRANSPORT | PHARMACOLOGY & PHARMACY | NANOVESICLES | Exosomes - metabolism | Paclitaxel - metabolism | Neoplasm Transplantation | Capillary Permeability | Paclitaxel - pharmacology | Humans | Brain Neoplasms - pathology | Doxorubicin - chemistry | Green Fluorescent Proteins - genetics | Brain Neoplasms - metabolism | Antineoplastic Agents - metabolism | Paclitaxel - chemistry | Endocytosis | Heterografts | Time Factors | Antineoplastic Agents - pharmacology | Doxorubicin - metabolism | Genes, Reporter | Disease Models, Animal | Animals, Genetically Modified | Endothelial Cells - metabolism | Brain Neoplasms - genetics | Technology, Pharmaceutical - methods | Zebrafish | Antineoplastic Agents - chemistry | Brain Neoplasms - drug therapy | Chemistry, Pharmaceutical | Blood-Brain Barrier - metabolism | Particle Size | Animals | Tumor Burden - drug effects | Green Fluorescent Proteins - biosynthesis | Cell Line, Tumor | Cell Proliferation - drug effects | Drug Delivery Systems - methods | Doxorubicin - pharmacology | Drugs | Drug delivery systems | Analysis | Brain cancer | Animal genetic engineering | Health aspects | Membrane proteins | Vehicles | Chemotherapy | Pharmacology | Blood-brain barrier
Journal Article